184 related articles for article (PubMed ID: 33427909)
1. A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin.
Nishida T; Kobayashi T; Sawa M; Masuda S; Shibasaki Y; Goto T; Fukuhara N; Fujii N; Ikegame K; Sugita J; Ikeda T; Kuwatsuka Y; Suzuki R; Najima Y; Doki N; Kato T; Inagaki Y; Utsu Y; Aotsuka N; Masuko M; Terakura S; Onishi Y; Maeda Y; Okada M; Teshima T; Murata M
Ann Hematol; 2021 Mar; 100(3):743-752. PubMed ID: 33427909
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of intrabone single unit cord blood transplantation for hematological malignancies.
Murata M; Maeda Y; Masuko M; Onishi Y; Endo T; Terakura S; Ishikawa Y; Iriyama C; Ushijima Y; Goto T; Fujii N; Tanimoto M; Kobayashi H; Shibasaki Y; Fukuhara N; Inamoto Y; Suzuki R; Kodera Y; Matsushita T; Kiyoi H; Naoe T; Nishida T
Cancer Sci; 2017 Aug; 108(8):1634-1639. PubMed ID: 28582607
[TBL] [Abstract][Full Text] [Related]
3. A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning.
Okada M; Tasaka T; Ikegame K; Aotsuka N; Kobayashi T; Najima Y; Matsuhashi Y; Wada H; Tokunaga H; Masuda S; Utsu Y; Yoshihara S; Kaida K; Daimon T; Ogawa H
Eur J Haematol; 2018 Apr; 100(4):335-343. PubMed ID: 29168236
[TBL] [Abstract][Full Text] [Related]
4. Intrabone Transplantation of a Single Unwashed Umbilical Cord Blood Unit with Antithymocyte Globulin-Free and Sirolimus-Based Graft-versus-Host Disease Prophylaxis: Fast Immune Reconstitution and Long-Term Disease Control in Patients with High-Risk Diseases.
Giglio F; Xue E; Barone A; Lorentino F; Greco R; Ruggeri A; Zambelli M; Parisi C; Milani R; Clerici D; Piemontese S; Marktel S; Lazzari L; Marcatti M; Bernardi M; Corti C; Lupo-Stanghellini MT; Ciceri F; Peccatori J
Transplant Cell Ther; 2023 Aug; 29(8):519.e1-519.e9. PubMed ID: 37244644
[TBL] [Abstract][Full Text] [Related]
5. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study.
Frassoni F; Gualandi F; Podestà M; Raiola AM; Ibatici A; Piaggio G; Sessarego M; Sessarego N; Gobbi M; Sacchi N; Labopin M; Bacigalupo A
Lancet Oncol; 2008 Sep; 9(9):831-9. PubMed ID: 18693069
[TBL] [Abstract][Full Text] [Related]
6. A phase I/II trial of intrabone marrow cord blood transplantation and comparison of the hematological recovery with the Japanese nationwide database.
Kurita N; Gosho M; Yokoyama Y; Kato T; Obara N; Sakata-Yanagimoto M; Hasegawa Y; Uchida N; Takahashi S; Kouzai Y; Atsuta Y; Kurata M; Ichinohe T; Chiba S
Bone Marrow Transplant; 2017 Apr; 52(4):574-579. PubMed ID: 28067880
[TBL] [Abstract][Full Text] [Related]
7. HLA 1-3 antigen-mismatched related peripheral blood stem cells transplantation using low-dose antithymocyte globulin versus unrelated cord blood transplantation.
Wada F; Watanabe M; Konuma T; Okabe M; Kobayashi S; Uchida N; Ikegame K; Tanaka M; Sugio Y; Mukae J; Onizuka M; Kawakita T; Kuriyama T; Takahashi S; Fukuda T; Nakano N; Sawa M; Kimura T; Ichinohe T; Atsuta Y; Kanda J;
Am J Hematol; 2022 Mar; 97(3):311-321. PubMed ID: 34978726
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
Sun ZM; Liu HL; Wu Y; Geng LQ; Zheng CC; Tang BL; Zhu XY; Tong J; Wang XB; Ding KY; Wan X; Zhang L; Yao W; Zhang XH; Han YS; Yang HZ; Liu X; Zhu WW; Wu JS; Wang ZY
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2214-9. PubMed ID: 27480651
[TBL] [Abstract][Full Text] [Related]
9. Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies.
Rocha V; Labopin M; Ruggeri A; Podestà M; Gallamini A; Bonifazi F; Sanchez-Guijo FM; Rovira M; Socie G; Baltadakis I; Michallet M; Deconinck E; Bacigalupo A; Mohty M; Gluckman E; Frassoni F
Transplantation; 2013 May; 95(10):1284-91. PubMed ID: 23507699
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.
Horwitz ME; Wease S; Blackwell B; Valcarcel D; Frassoni F; Boelens JJ; Nierkens S; Jagasia M; Wagner JE; Kuball J; Koh LP; Majhail NS; Stiff PJ; Hanna R; Hwang WYK; Kurtzberg J; Cilloni D; Freedman LS; Montesinos P; Sanz G
J Clin Oncol; 2019 Feb; 37(5):367-374. PubMed ID: 30523748
[TBL] [Abstract][Full Text] [Related]
12. Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study.
Sun Z; Liu H; Luo C; Geng L; Zheng C; Tang B; Zhu X; Tong J; Wang X; Ding K; Wan X; Zhang L; Yao W; Song K; Zhang X; Wu Y; Yang H; Han Y; Liu X; Zhu W; Wu J; Wang Z
Int J Cancer; 2018 Aug; 143(3):699-708. PubMed ID: 29473150
[TBL] [Abstract][Full Text] [Related]
13. Intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: a phase I study.
Okada M; Yoshihara S; Taniguchi K; Kaida K; Ikegame K; Kato R; Tamaki H; Inoue T; Soma T; Kai S; Kato S; Ogawa H
Biol Blood Marrow Transplant; 2012 Apr; 18(4):633-9. PubMed ID: 21867667
[TBL] [Abstract][Full Text] [Related]
14. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
Inamoto Y; Kimura F; Kanda J; Sugita J; Ikegame K; Nakasone H; Nannya Y; Uchida N; Fukuda T; Yoshioka K; Ozawa Y; Kawano I; Atsuta Y; Kato K; Ichinohe T; Inoue M; Teshima T;
Haematologica; 2016 Dec; 101(12):1592-1602. PubMed ID: 27662017
[TBL] [Abstract][Full Text] [Related]
15. Comparison of conditioning regimens with or without antithymocyte globulin for unrelated cord blood transplantation in children with high-risk or advanced hematological malignancies.
Zheng C; Luan Z; Fang J; Sun X; Chen J; Li CK; Hu S; Zhu Y; Sun Z
Biol Blood Marrow Transplant; 2015 Apr; 21(4):707-12. PubMed ID: 25598277
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of unrelated umbilical cord blood transplantation for 25 patients with hematological diseases].
Chang HR; Cheng Z; Chen GH; Sun AN; Qiao M; Ma X; Wang Y; Chen F; Jin HY; Lu Y; Zhang JQ; Fu CC; Jin ZM; Tang XW; Han Y; Qiu HY; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):767-73. PubMed ID: 24989292
[TBL] [Abstract][Full Text] [Related]
17. [Unrelated umbilical cord blood transplantation with TBI/Ara-c/CY non-ATG conditioning regimen for adults with hematologic malignancies].
Sun ZM; Liu HL; Geng LQ; Zhou CY; Wang XB; Ding KY; Tong J; Zhu WB; Liu X; Wang ZY
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(24):1660-4. PubMed ID: 22944153
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.
Mori T; Aisa Y; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Yamane A; Ikeda Y; Okamoto S
Transplant Proc; 2007 Jun; 39(5):1615-9. PubMed ID: 17580201
[TBL] [Abstract][Full Text] [Related]
19. Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in China.
Tong J; Xuan L; Sun Y; Huang D; Liu H; Zheng C; Zhu X; Tang B; Song K; Zhang X; Zhang L; Yao W; Lin D; Liu Q; Sun Z
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1541-1548. PubMed ID: 28499936
[TBL] [Abstract][Full Text] [Related]
20. Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin.
Politikos I; Devlin SM; Arcila ME; Barone JC; Maloy MA; Naputo KA; Ruiz JD; Mazis CM; Scaradavou A; Avecilla ST; Dahi PB; Giralt SA; Hsu KC; Jakubowski AA; Papadopoulos EB; Perales MA; Sauter CS; Tamari R; Ponce DM; O'Reilly RJ; Barker JN
Leukemia; 2021 Mar; 35(3):850-862. PubMed ID: 32555371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
